Damora Therapeutics, Inc. Ordinary Shares (DMRA) News
Latest headlines that mention DMRA, newest first · each headline opens the original publisher
- Last price
- $21.26
- Day change
- +0.81%
- Next earnings
- 2026-11-05
DMRA headlines
latest coverageNot much coverage yet. DMRA has appeared in only a few headlines lately; new stories show up here as publishers cover it.
This clinical-stage biotech develops small molecule therapies for cancer and fibrotic diseases, focusing on galectin-3 and LOXL2 inhibitors.
DMRA news alerts
Get an alert by email or push when a new headline mentions DMRA.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.